SMITH ASSET MANAGEMENT GROUP LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 172 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,000
+16.7%
1500.0%0.00%
Q1 2021$6,000
-96.8%
150
-96.6%
0.00%
-100.0%
Q4 2020$190,000
+62.4%
4,4400.0%0.01%
+83.3%
Q3 2020$117,000
-17.6%
4,440
-16.1%
0.01%
-25.0%
Q2 2020$142,000
+47.9%
5,290
-1.1%
0.01%
+60.0%
Q1 2020$96,000
+1.1%
5,3500.0%0.01%
+25.0%
Q4 2019$95,000
+14.5%
5,3500.0%0.00%
+33.3%
Q3 2019$83,000
+22.1%
5,350
+34.4%
0.00%
+50.0%
Q2 2019$68,000
+6.2%
3,9800.0%0.00%0.0%
Q1 2019$64,000
-73.3%
3,980
-75.7%
0.00%
-75.0%
Q4 2018$240,000
-21.3%
16,380
-2.4%
0.01%
-11.1%
Q3 2018$305,000
+16.0%
16,780
+7.7%
0.01%
+12.5%
Q2 2018$263,000
-13.8%
15,5800.0%0.01%
-20.0%
Q1 2018$305,000
-44.2%
15,580
-42.3%
0.01%
-41.2%
Q4 2017$547,000
+16.6%
26,9800.0%0.02%
+6.2%
Q3 2017$469,000
+35.5%
26,9800.0%0.02%
+45.5%
Q2 2017$346,000
-5.2%
26,980
-4.3%
0.01%0.0%
Q1 2017$365,000
+30.8%
28,180
-0.1%
0.01%
+37.5%
Q4 2016$279,000
-18.2%
28,2000.0%0.01%
-20.0%
Q3 2016$341,000
+40.3%
28,2000.0%0.01%
+42.9%
Q2 2016$243,000
-10.0%
28,200
-1.1%
0.01%
-12.5%
Q1 2016$270,000
-64.1%
28,500
-34.3%
0.01%
-63.6%
Q4 2015$752,000
+11.7%
43,380
-13.4%
0.02%
-15.4%
Q3 2015$673,00050,0800.03%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders